$2.40 +0.06 (2.56%) Rigel Pharmaceuticals Inc - NASDAQ

Feb. 11, 2016 | 04:00 PM
Key Statistics
Last Trade: 2.40
Trade Time: Feb 11 04:00 PM Eastern Daylight Time
Change: +0.06 (2.56%)
Prev Close: 2.34
Open: 2.29
Bid: 2.40
Ask: 2.41

Competitors

Ticker Name Volume % Change
PFE Pfizer Inc 39.40M -1.22%
MYL Mylan N.V. 33.27M -18.05%
JNJ Johnson & Johnson 12.35M -0.03%
MRK Merck & Co Inc 10.75M -1.37%
TEVA Teva Pharma Ind Shs Sponsored American Deposit Receipt Repr 1 Sh 9.29M -4.97%

RIGL Stock Analysis

  1. No results found.

Partner Headlines

  1. Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP

    Benzinga | Jan. 28, 2016 | 07:37AM EST
  2. Rigel Granted Orphan Drug Designation for Fostamatinib in ITP

    Benzinga | Sep. 8, 2015 | 07:30AM EST
  3. Earnings Scheduled For March 3, 2015

    Benzinga | Mar. 3, 2015 | 04:18AM EST
  4. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  5. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  6. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST